These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10519454)

  • 1. Severe side effects and drug plasma concentrations in preterm infants treated with doxapram.
    Barbé F; Hansen C; Badonnel Y; Legagneur H; Vert P; Boutroy MJ
    Ther Drug Monit; 1999 Oct; 21(5):547-52. PubMed ID: 10519454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal absorption of doxapram in neonates.
    Bairam A; Akramoff-Gershan L; Beharry K; Laudignon N; Papageorgiou A; Aranda JV
    Am J Perinatol; 1991 Mar; 8(2):110-3. PubMed ID: 2006935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants.
    Flint RB; Weteringen WV; Voller S; Poppe JA; Koch BCP; de Groot R; Tibboel D; Knibbe CAJ; Reiss IKM; Simons SHP; Dino Research Group
    Curr Pharm Des; 2017; 23(38):5919-5927. PubMed ID: 28925893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioavailability and maturing clearance of doxapram in preterm infants.
    Flint RB; Simons SHP; Andriessen P; Liem KD; Degraeuwe PLJ; Reiss IKM; Ter Heine R; Engbers AGJ; Koch BCP; Groot R; Burger DM; Knibbe CAJ; Völler S;
    Pediatr Res; 2021 Apr; 89(5):1268-1277. PubMed ID: 32698193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT interval lengthening in premature infants treated with doxapram.
    Maillard C; Boutroy MJ; Fresson J; Barbé F; Hascoët JM
    Clin Pharmacol Ther; 2001 Dec; 70(6):540-5. PubMed ID: 11753270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
    Greze E; Benard M; Hamon I; Casper C; Haddad FE; Boutroy MJ; Hascoët JM
    Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolites of doxapram in premature neonates.
    Coutts RT; Jamali F; Malek F; Peliowski A; Finer NN
    Xenobiotica; 1991 Oct; 21(10):1407-18. PubMed ID: 1796617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxapram treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2000; (2):CD000074. PubMed ID: 10796114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose doxapram therapy in premature infants and its CSF and serum concentrations.
    Kumita H; Mizuno S; Shinohara M; Ichikawa T; Yamazaki T
    Acta Paediatr Scand; 1991; 80(8-9):786-91. PubMed ID: 1957596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood potassium and urine aldosterone after doxapram therapy for preterm infants.
    Shimokaze T; Toyoshima K; Shibasaki J; Itani Y
    J Perinatol; 2018 Jun; 38(6):702-707. PubMed ID: 29515224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxapram and hypokalaemia in very preterm infants.
    Fischer C; Ferdynus C; Gouyon JB; Semama DS
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F416-8. PubMed ID: 23448699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral administration of doxapram in preterm neonates with aminophylline-resistant idiopathic apnea crisis].
    Romeo MG; Betta P; Tina LG; Cilauro S; Saporito A; Distefano G
    Pediatr Med Chir; 1995; 17(2):123-6. PubMed ID: 7610073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
    Poets CF; Darraj S; Bohnhorst B
    Biol Neonate; 1999 Oct; 76(4):207-13. PubMed ID: 10473894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain hemodynamic effects of doxapram in preterm infants.
    Dani C; Bertini G; Pezzati M; Pratesi S; Filippi L; Tronchin M; Rubaltelli FF
    Biol Neonate; 2006; 89(2):69-74. PubMed ID: 16158005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplitude-integrated electroencephalography shows that doxapram influences the brain activity of preterm infants.
    Czaba-Hnizdo C; Olischar M; Rona Z; Weninger M; Berger A; Klebermass-Schrehof K
    Acta Paediatr; 2014 Sep; 103(9):922-7. PubMed ID: 24813556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride.
    Miyata M; Hata T; Kato N; Takeuchi M; Mizutani H; Kubota M; Yamazaki T
    J Perinat Med; 2007; 35(4):330-3. PubMed ID: 17614751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of doxapram on cerebral blood flow velocity in preterm infants.
    Roll C; Horsch S
    Neuropediatrics; 2004 Apr; 35(2):126-9. PubMed ID: 15127312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxapram metabolism in human fetal hepatic organ culture.
    Bairam A; Branchaud C; Beharry K; Rex J; Laudignon N; Papageorgiou A; Aranda JV
    Clin Pharmacol Ther; 1991 Jul; 50(1):32-8. PubMed ID: 1855351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue.
    Kraft M; Foerster KI; Wiedmann F; Sauter M; Paasche A; Blochberger PL; Yesilgöz B; L'hoste Y; Frey N; Haefeli WE; Burhenne J; Schmidt C
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.